Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Greiner Bio-One has over six decades of experience as a global leader in the development and manufacture of plastic-based laboratory products. The company’s innovations include the first disposable plastic Petri dish and evacuated blood collection system. Its portfolio supports clinical diagnostics, life science research—including drug discovery—and medical device sterilization. The business remains active with around 2,800 employees at 29 locations worldwide as of 2023–2024.
No clinical results are reported since the company does not develop drugs or biologics.
Demand stabilized in its core business units through 2023–2024 with continued growth expected into 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Greiner Bio-One.